Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL | MicrobiomeTrials← Back to trialsNCT06052696
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2024-03-01Est. Completion: 2028-12-01
Enrollment target: 500 participants Locations- Erasmus MC, Rotterdam, Netherlands
Other microbiome trials you might be interested in
Papillomavirus Infections
This study will evaluate the efficacy, immunogenicity and safety of 9-valent human papillomavirus (9vHPV; V503) vaccine …
Guilin, ChinaEst. completion Mar 31, 2028
Human Papilloma VirusHuman Immunodeficiency VirusAnal Intraepithelial NeoplasiaHigh-Grade Squamous Intraepithelial Lesions
The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar…
Atlanta, United StatesEst. completion Dec 2027